Kevin A. Waschke
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Kevin A. Waschke has a total of 102 co-authors. Here are the top co-authors by number of shared publications:
- Ivan V. Litvinov
Department of Specialized Medicine (Dermatology), St Mary’s Hospital Centre, Montreal, QC, Canada
4 shared publications - Alan N. Barkun
Division of Gastroenterology, McGill University Health Center, McGill University, Montreal, Quebec, Canada
2 shared publications Denis Sasseville
Division of Dermatology, McGill University, Montreal, Quebec, Canada
2 shared publications- Elham Rahme
McGill University
2 shared publications - Feras M. Ghazawi
Division of Dermatology, University of Ottawa, Ottawa, ON, Canada
2 shared publications - Gurpal Sandha
Department of Medicine, University of Alberta Hospital , Edmonton, Alberta, T6G 2X8
2 shared publications
Latest Publications
- 20 September 2024
- Published by Elsevier in Gastroenterology Clinics of North America
- Vol. 53 (4) , 521-529
Endoscopic Education, Training, and Simulation
- 20 September 2024
- Published by Elsevier in Gastroenterology Clinics of North America
- Vol. 53 (4) , 521-529
Endoscopic Education, Training, and Simulation
- 16 June 2022
- Published by Elsevier in Gastroenterology
- Vol. 162 (7)
867c: ENDOSCOPIC ULTRASOUND-GUIDED BILIARY DRAINAGE OF FIRST INTENT WITH A LUMEN-APPOSING METAL STENT VS. ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY IN MALIGNANT DISTAL BILIARY OBSTRUCTION: A MULTICENTER RANDOMIZED CONTROLLED TRIAL (ELEMENT TRIAL)
- 16 June 2022
- Published by Elsevier in Gastroenterology
- Vol. 162 (7)
867c: ENDOSCOPIC ULTRASOUND-GUIDED BILIARY DRAINAGE OF FIRST INTENT WITH A LUMEN-APPOSING METAL STENT VS. ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY IN MALIGNANT DISTAL BILIARY OBSTRUCTION: A MULTICENTER RANDOMIZED CONTROLLED TRIAL (ELEMENT TRIAL)
- Open Access
- 28 May 2021
- Published by MDPI AG in Current Oncology
- Vol. 28 (3) , 2052-2064
Geographic and Socioeconomic Disparity of Gastric Cancer Patients in Canada
Gastric cancer is the 5th most common malignancy worldwide, representing ~5–10% of all new cancer cases. Although its incidence is declining, it is estimated that 1 in 98 Canadians will develop gastric cancer in their lifetime. The epidemiology and distribution of gastric cancer throughout Canada, however, remains poorly understood. A retrospective analysis of demographic data across Canada between 1992 and 2010 was performed using 2 population-based cancer registries. The incidence of gastric cancer was examined at the levels of provinces, cities, and postal codes. In addition, 43,955 patients were diagnosed with gastric cancer in Canada between 1992 and 2010; 66% were male and the average age of diagnosis was 68.4 years. The age-adjusted incidence rate was 5.07 cases per 100,000 individuals per year. The incidence decreased over the study period by 30%. High incidence rates were identified in rural areas of Newfoundland and Labrador, New Brunswick, and Quebec. Our study found a significant association between gastric cancer incidence rates and lower socioeconomic status, as well as Hispanic ethnicity. This is the first study to provide a comprehensive analysis of the incidence of gastric carcinoma in Canada, identifying high-risk populations that may benefit from increased primary and secondary prevention.
- 28 May 2021
- Published by MDPI AG in Current Oncology
- Vol. 28 (3) , 2052-2064
Open AccessGeographic and Socioeconomic Disparity of Gastric Cancer Patients in Canada
Gastric cancer is the 5th most common malignancy worldwide, representing ~5–10% of all new cancer cases. Although its incidence is declining, it is estimated that 1 in 98 Canadians will develop gastric cancer in their lifetime. The epidemiology and distribution of gastric cancer throughout Canada, however, remains poorly understood. A retrospective analysis of demographic data across Canada between 1992 and 2010 was performed using 2 population-based cancer registries. The incidence of gastric cancer was examined at the levels of provinces, cities, and postal codes. In addition, 43,955 patients were diagnosed with gastric cancer in Canada between 1992 and 2010; 66% were male and the average age of diagnosis was 68.4 years. The age-adjusted incidence rate was 5.07 cases per 100,000 individuals per year. The incidence decreased over the study period by 30%. High incidence rates were identified in rural areas of Newfoundland and Labrador, New Brunswick, and Quebec. Our study found a significant association between gastric cancer incidence rates and lower socioeconomic status, as well as Hispanic ethnicity. This is the first study to provide a comprehensive analysis of the incidence of gastric carcinoma in Canada, identifying high-risk populations that may benefit from increased primary and secondary prevention.
- Open Access
- 27 January 2021
- Published by Oxford University Press (OUP) in Journal of the Canadian Association of Gastroenterology
- Vol. 4 (1) , 49
COVID-19 Vaccination in Patients With Inflammatory Bowel Disease: Communiqué From the Canadian Association of Gastroenterology
- 27 January 2021
- Published by Oxford University Press (OUP) in Journal of the Canadian Association of Gastroenterology
- Vol. 4 (1) , 49
Open AccessCOVID-19 Vaccination in Patients With Inflammatory Bowel Disease: Communiqué From the Canadian Association of Gastroenterology
- Open Access
- 22 June 2020
- Published by Oxford University Press (OUP) in Journal of the Canadian Association of Gastroenterology
- Vol. 3 (5) , 243-245
COVID-19: Framework for the Resumption of Endoscopic Activities From the Canadian Association of Gastroenterology
- 22 June 2020
- Published by Oxford University Press (OUP) in Journal of the Canadian Association of Gastroenterology
- Vol. 3 (5) , 243-245
Open AccessCOVID-19: Framework for the Resumption of Endoscopic Activities From the Canadian Association of Gastroenterology
- Open Access
- 1 June 2020
- Published by MDPI AG in Current Oncology
- Vol. 27 (3) , 294-306
Investigating Epidemiologic Trends and the Geographic Distribution of Patients with Anal Squamous Cell Carcinoma throughout Canada
Background Anal cancer is a rare disease, constituting 0.5% of new cancer cases in the United States. The most common subtype is squamous cell carcinoma (scc). Studies in several developed nations have reported on an increasing incidence of anal cancer in recent decades, and various risk factors pertaining to the pathogenesis of the disease have been identified, including infection with the human papillomavirus, tobacco use, and immunosuppression. The epidemiology and distribution of anal scc throughout Canada remain poorly understood, however. Methods Using 3 population-based cancer registries, a retrospective analysis of demographic data across Canada for 1992–2010 was performed. The incidence and mortality for anal scc was examined at the levels of provinces, cities, and the forward sortation area (FSA) component (first 3 characters) of postal codes. Results During 1992–2010, 3720 individuals were diagnosed with anal scc in Canada; 64% were women. The overall national incidence rate was 6.3 cases per million population per year, with an average age at diagnosis of 60.4 years. The incidence increased over time, with significantly higher incidence rates documented in British Columbia and Nova Scotia (9.3 cases per million population each). Closer examination revealed clustering of cases in various urban centres and self-identified lgbtq communities in Toronto, Montreal, and Vancouver. Discussion This study provides, for the first time, a comprehensive analysis of the burden of anal scc in Canada, identifying susceptible populations and shedding light onto novel avenues of research to lower the incidence of anal cancer throughout the country.
- 1 June 2020
- Published by MDPI AG in Current Oncology
- Vol. 27 (3) , 294-306
Open AccessInvestigating Epidemiologic Trends and the Geographic Distribution of Patients with Anal Squamous Cell Carcinoma throughout Canada
Background Anal cancer is a rare disease, constituting 0.5% of new cancer cases in the United States. The most common subtype is squamous cell carcinoma (scc). Studies in several developed nations have reported on an increasing incidence of anal cancer in recent decades, and various risk factors pertaining to the pathogenesis of the disease have been identified, including infection with the human papillomavirus, tobacco use, and immunosuppression. The epidemiology and distribution of anal scc throughout Canada remain poorly understood, however. Methods Using 3 population-based cancer registries, a retrospective analysis of demographic data across Canada for 1992–2010 was performed. The incidence and mortality for anal scc was examined at the levels of provinces, cities, and the forward sortation area (FSA) component (first 3 characters) of postal codes. Results During 1992–2010, 3720 individuals were diagnosed with anal scc in Canada; 64% were women. The overall national incidence rate was 6.3 cases per million population per year, with an average age at diagnosis of 60.4 years. The incidence increased over time, with significantly higher incidence rates documented in British Columbia and Nova Scotia (9.3 cases per million population each). Closer examination revealed clustering of cases in various urban centres and self-identified lgbtq communities in Toronto, Montreal, and Vancouver. Discussion This study provides, for the first time, a comprehensive analysis of the burden of anal scc in Canada, identifying susceptible populations and shedding light onto novel avenues of research to lower the incidence of anal cancer throughout the country.
- Open Access
- 12 November 2019
- Published by Wiley in Cancer Medicine
- Vol. 9 (1) , 401-417
Epidemiologic trends and geographic distribution of esophageal cancer in Canada: A national population‐based study
Background: Esophageal cancer can be subdivided into two main histological subtypes with significant variability in their etiology and epidemiology. The incidence of esophageal adenocarcinoma (AC) is increasing across the developed countries, whereas the incidence of esophageal squamous cell carcinoma (SCC) is declining. Several risk factors have been identified in the pathogenesis of each subtype, however, their epidemiologic characteristics and distribution throughout Canada remain poorly understood.Methods: We performed a retrospective analysis of demographic data across Canada from 1992 to 2010 using two independent population‐based cancer registries. The incidence of esophageal cancer, for each subtype, was examined at the levels of provinces/territories, cities, and postal codes.Results: A total of 19 790 patients were diagnosed with esophageal cancer in Canada between 1992 and 2010; 74% were males. The average national incidence rate was 33.5 cases per million individuals per year. Incidence of esophageal AC increased over time, with notable high‐incidence rates on the Vancouver Island, the coasts of the Great Lakes, and the coasts of the Northumberland Strait in the Maritimes. The overall incidence of esophageal SCC has decreased. However, high incidence of esophageal SCC was detected in the Vancouver city, rural eastern Québec, and in the Maritimes. We also report clustering for each subtype using postal codes, which sheds light onto new avenues of research for potential environmental etiologies.Conclusions: This study, for the first time, provides a detailed analysis on the burden of esophageal cancer in Canada, revealing important geographic clustering trends.
- 12 November 2019
- Published by Wiley in Cancer Medicine
- Vol. 9 (1) , 401-417
Open AccessEpidemiologic trends and geographic distribution of esophageal cancer in Canada: A national population‐based study
Background: Esophageal cancer can be subdivided into two main histological subtypes with significant variability in their etiology and epidemiology. The incidence of esophageal adenocarcinoma (AC) is increasing across the developed countries, whereas the incidence of esophageal squamous cell carcinoma (SCC) is declining. Several risk factors have been identified in the pathogenesis of each subtype, however, their epidemiologic characteristics and distribution throughout Canada remain poorly understood.Methods: We performed a retrospective analysis of demographic data across Canada from 1992 to 2010 using two independent population‐based cancer registries. The incidence of esophageal cancer, for each subtype, was examined at the levels of provinces/territories, cities, and postal codes.Results: A total of 19 790 patients were diagnosed with esophageal cancer in Canada between 1992 and 2010; 74% were males. The average national incidence rate was 33.5 cases per million individuals per year. Incidence of esophageal AC increased over time, with notable high‐incidence rates on the Vancouver Island, the coasts of the Great Lakes, and the coasts of the Northumberland Strait in the Maritimes. The overall incidence of esophageal SCC has decreased. However, high incidence of esophageal SCC was detected in the Vancouver city, rural eastern Québec, and in the Maritimes. We also report clustering for each subtype using postal codes, which sheds light onto new avenues of research for potential environmental etiologies.Conclusions: This study, for the first time, provides a detailed analysis on the burden of esophageal cancer in Canada, revealing important geographic clustering trends.
- 1 July 2019
- Published by Elsevier in Gastrointestinal Endoscopy
- Vol. 90 (1) , 27-34
ASGE principles of endoscopic training
- 1 July 2019
- Published by Elsevier in Gastrointestinal Endoscopy
- Vol. 90 (1) , 27-34
ASGE principles of endoscopic training
- 1 May 2018
- Published by Elsevier in Gastroenterology
- Vol. 154 (7) , 1985-1992
Advances and Challenges in Endoscopic Training
- 1 May 2018
- Published by Elsevier in Gastroenterology
- Vol. 154 (7) , 1985-1992
Advances and Challenges in Endoscopic Training